Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.09M | Buy |
11,584
+5,101
| +79% | +$1.38M | 0.01% | 508 |
|
|
2025
Q4 | $1.63M | Buy |
6,483
+2,073
| +47% | +$551K | 0.01% | 644 |
|
|
2025
Q3 | $1.27M | Buy |
+4,410
| New | +$1.18M | 0.01% | 636 |
|
|
2025
Q2 | – | Sell |
-7,505
| Closed | -$1.72M | – | 1109 |
|
|
2025
Q1 | $1.72M | Buy |
7,505
+2,366
| +46% | +$574K | 0.01% | 460 |
|
|
2024
Q4 | $1.18M | Buy |
5,139
+1,173
| +30% | +$269K | 0.01% | 572 |
|
|
2024
Q3 | $886K | Sell |
3,966
-7,893
| -67% | -$1.73M | 0.01% | 547 |
|
|
2024
Q2 | $2.41M | Buy |
11,859
+7,819
| +194% | +$1.59M | 0.01% | 381 |
|
|
2024
Q1 | $883K | Sell |
4,040
-70
| -2% | -$15.4K | ﹤0.01% | 546 |
|
|
2023
Q4 | $934K | Sell |
4,110
-80
| -2% | -$16.8K | 0.01% | 536 |
|
|
2023
Q3 | $842K | Sell |
4,190
-7,294
| -64% | -$1.54M | 0.01% | 527 |
|
|
2023
Q2 | $2.38M | Buy |
11,484
+6,467
| +129% | +$1.25M | 0.02% | 399 |
|
|
2023
Q1 | $989K | Sell |
5,017
-12,031
| -71% | -$2.48M | 0.01% | 523 |
|
|
2022
Q4 | $3.45M | Buy |
17,048
+5,082
| +42% | +$993K | 0.02% | 444 |
|
|
2022
Q3 | $2.11M | Sell |
11,966
-6,856
| -36% | -$1.4M | 0.01% | 595 |
|
|
2022
Q2 | $3.79M | Sell |
18,822
-178,165
| -90% | -$38M | 0.01% | 514 |
|
|
2022
Q1 | $44.6M | Buy |
196,987
+174,308
| +769% | +$41M | 0.16% | 144 |
|
|
2021
Q4 | $6.12M | Sell |
22,679
-49,110
| -68% | -$12.2M | 0.02% | 511 |
|
|
2021
Q3 | $17.4M | Buy |
71,789
+42,564
| +146% | +$10.7M | 0.06% | 257 |
|
|
2021
Q2 | $6.93M | Buy |
29,225
+559
| +2% | +$127K | 0.03% | 332 |
|
|
2021
Q1 | $6.28M | Sell |
28,666
-27,242
| -49% | -$5.47M | 0.02% | 468 |
|
|
2020
Q4 | $9.78M | Buy |
55,908
+48,210
| +626% | +$8.33M | 0.04% | 394 |
|
|
2020
Q3 | $1.25M | Sell |
7,698
-12,692
| -62% | -$2.01M | 0.01% | 488 |
|
|
2020
Q2 | $2.91M | Buy |
+20,390
| New | +$2.82M | 0.02% | 362 |
|
|
2020
Q1 | – | Sell |
-38,446
| Closed | -$5.56M | – | 806 |
|
|
2019
Q4 | $5.56M | Buy |
+38,446
| New | +$5.55M | 0.03% | 391 |
|
|
2019
Q1 | – | Sell |
-160,361
| Closed | -$17.4M | – | 839 |
|
|
2018
Q4 | $17.4M | Buy |
160,361
+115,348
| +256% | +$15.5M | 0.14% | 157 |
|
|
2018
Q3 | $6.72M | Buy |
45,013
+6,822
| +18% | +$1.04M | 0.04% | 339 |
|
|
2018
Q2 | $5.89M | Sell |
38,191
-6,443
| -14% | -$973K | 0.03% | 359 |
|
|
2018
Q1 | $6.2M | Buy |
+44,634
| New | +$6.56M | 0.04% | 330 |
|
|
2017
Q4 | – | Sell |
-12,628
| Closed | -$1.64M | – | 1023 |
|
|
2017
Q3 | $1.64M | Buy |
+12,628
| New | +$1.68M | 0.02% | 447 |
|
|
2017
Q2 | – | Sell |
-87,271
| Closed | -$10.8M | – | 911 |
|
|
2017
Q1 | $10.8M | Buy |
87,271
+72,276
| +482% | +$8.56M | 0.13% | 160 |
|
|
2016
Q4 | $1.65M | Buy |
+14,995
| New | +$1.67M | 0.02% | 383 |
|
|
2016
Q3 | – | Sell |
-113,917
| Closed | -$12.7M | – | 554 |
|
|
2016
Q2 | $12.7M | Buy |
113,917
+12,566
| +12% | +$1.35M | 0.24% | 96 |
|
|
2016
Q1 | $10.2M | Buy |
+101,351
| New | +$9.72M | 0.17% | 98 |
|
|
2015
Q3 | – | Sell |
-2,099
| Closed | -$219K | – | 357 |
|
|
2015
Q2 | $219K | Sell |
2,099
-85
| -4% | -$8.85K | ﹤0.01% | 331 |
|
|
2015
Q1 | $237K | Sell |
2,184
-804
| -27% | -$82.7K | ﹤0.01% | 379 |
|
|
2014
Q4 | $277K | Sell |
2,988
-64
| -2% | -$5.65K | ﹤0.01% | 333 |
|
|
2014
Q3 | $267K | Hold |
3,052
| – | – | ﹤0.01% | 358 |
|
|
2014
Q2 | $268K | Buy |
+3,052
| New | +$264K | ﹤0.01% | 412 |
|
Other funds holding LH
VCM
VPM
Natixis's LH Position: Q1 2026 in Review
Natixis increased its Labcorp (LH) stake by 79% in Q1 2026, buying an estimated $1.38M and bringing the position to 11,584 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #508.
Natixis first reported a position in LH in Q2 2014 and has held it in 38 quarters since. The position peaked at $44.6M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Natixis held 11,584 shares of Labcorp worth $3.09M as of Q1 2026.
- Natixis bought 5,101 Labcorp shares in Q1 2026, an estimated $1.38M.
- Labcorp made up 0.01% of Natixis's portfolio in Q1 2026, its #508 holding.
- Natixis first reported a position in Labcorp in Q2 2014 and has held it in 38 quarters since.
- Natixis's Labcorp position peaked at $44.6M in Q1 2022.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.